Avalo Therapeutics Inc. (AVTX) stock is currently valued at $0.14. During the last session, the stock experienced a remarkable rise, reaching $0.296 after opening at $0.2834. The stock briefly dropped to $0.2035 before ultimately closing at $0.22.
In terms of market performance, Avalo Therapeutics Inc. had a fairly uneven. The highest value for the stock in the past year was $7.00 on 11/07/22, and the lowest value was recorded at $0.08 on 09/11/23.
Top 5 EV Tech Stocks to Buy for 2023
The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".
Click Here to Download the FREE Report.
Sponsored
52-week price history of AVTX Stock
Studying a stock’s 52-week price history, which includes both low and high prices, can help gauge its current status and potential future performance. Avalo Therapeutics Inc.’s current trading price is -98.01% away from its 52-week high, while its distance from the 52-week low is 72.95%. The stock’s price range during the 52-week period has remained between $0.08 and $7.00. In the Healthcare sector, the company’s shares saw a trading volume of around 67.84 million for the day, which was evidently higher than the average daily volume of 22.13 million over the past three months.
Market Capitalization and Financial Performance: An In-Depth Look
Avalo Therapeutics Inc. (AVTX) has experienced a quarterly decline of -96.30% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 2.85M and boasts a workforce of 20 employees.
Making Sense of Trading Volume and Moving Average Data
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.4588, with a change in price of -2.9519. Similarly, Avalo Therapeutics Inc. recorded 14,621,938 in trading volume during the last 100 days, posting a change of -95.53%.
AVTX Stock Stochastic Average
Avalo Therapeutics Inc.’s raw stochastic average for the past 50 days is presently 19.88%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 26.69%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 53.03% and 50.04%, respectively.
AVTX Stock Price Performance Analysis
The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. Until today this year the stock’s price performance recorded a decrease of -97.23%. However, over the last six months, the performance has been stronger by -94.51%. The price of AVTX increased 8.74% over the last 30 days. And in the last five days, it has surged by 49.89%.
